Richard Schlegel Receives Oscar B. Hunter Chair in Pathology

Inventor of HPV vaccine recognized with endowed chair

December 18, 2009

Dr. Richard Schlegel
Dr. Richard Schlegel

C. Richard Schlegel, MD, PhD, academic chair and professor in the department of pathology, was celebrated as the newest occupant of the Oscar B. Hunter Chair in pathology on Dec. 14, 2009. Schlegel is an inventor of the human papillomavirus (HPV) vaccine that was approved to prevent the virus in 2006 by the U.S. Food and Drug Administration. Schlegel’s current focus is developing second- and third-generation vaccines that could be used to prevent HPV and decrease its incidence in the developing world, where nearly 400,000 women are diagnosed annually with cervical cancer which is often caused by HPV.

The Chair was established in 1972 in memory of leading pathologist Dr. Oscar B. Hunter Sr. and supports outstanding investigators and teachers who will continue to flourish in the field of pathological research.

“Dr. Schlegel embodies everything we mean when we talk about our approach to translational research at GUMC, cura personalis, or ‘smart science with a heart,’” said Howard J. Federoff, executive vice president for health sciences. “His motivating passion has been and continues to be the development of a low-cost, stable vaccine for cervical cancer that kills a quarter-of-a-million women every year.”

As the Oscar B. Hunter Chair, Schlegel will continue to lead Georgetown’s fight in the prevention and treatment of cervical cancer in the United States and around the world.

Originally published on the GUMC Update

Author: GUMC Communications